Al-Shamsi Humaid O, Abyad Amin, Kaloyannidis Panayotis, El-Saddik Amro, Alrustamani Ahmad, Abu Gheida Ibrahim, Ziade Azzam, Dreier Norbert W, Ul-Haq Urfan, Joshua Thanda Lucy Ann, El Kinge Abdul Rahman, Coelho Ritika, Ibrahim Dima, Afrit Mehdi, Al-Lababidi Bilal, Aabideen Zainul, Sabhani Mayur, Shah Rakeshkumar, Makhlouf Ghaith, Iskandaerani Lana, Iqbal Faryal, Narayanan Shiny, Ameen Mohammed, Morrison Theresa, Khalil Charbel, Mheidly Kayane
Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.
Clin Pract. 2022 Jan 28;12(1):84-90. doi: 10.3390/clinpract12010010.
Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in view of the lack of a comprehensive HSCT facility that could offer the full spectrum of interventions and monitoring protocols. This comes with considerable challenges related to coverage and logistics of travel. It also limits the continuity of clinical care, and presents inconvenience to patients who come from a different cultural background. In this article, we share our experiences and lessons learned during the establishment of the first comprehensive adult and pediatric HSCT unit in the UAE that is designed to cater for local citizens and residents, as well as neighboring countries facing similar availability challenges.
造血干细胞移植（HSCT）越来越多地被用于治疗各种恶性和非恶性疾病。在阿拉伯联合酋长国（UAE），鉴于缺乏能够提供全方位干预措施和监测方案的综合性HSCT设施，可能从该手术中受益的患者通常需要到国外寻求医疗服务。这带来了与保险范围和旅行后勤相关的重大挑战。它还限制了临床护理的连续性，给来自不同文化背景的患者带来不便。在本文中，我们分享了在阿联酋建立首个综合性成人及儿童HSCT科室的过程中的经验和教训，该科室旨在为当地公民和居民以及面临类似医疗服务可及性挑战的邻国提供服务。
